Antidepressants and Advertising: Psychopharmaceuticals in Crisis

4
441

An article by written by faculty of the Harvard History of Science Department and the Program in Placebo Studies explores how “drug marketing portrays idealized scientific relationships between psychopharmaceuticals and depression … and how the placebo effect has become a critical issue in these debates, including the possible role of drug advertising to influence the placebo effect directly.” The article appears in the Yale Journal of Biology and Medicine.

Article → 

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articlePlaying Hide-and-Seek with Psychiatric Drug Studies
Next articleChildhood Adversity Increases Psychosis
Kermit Cole
Kermit Cole is a licensed marriage and family therapist based in Santa Fe, New Mexico. He and his partner, Luisa Putnam, joined by their mutual interest in working with trauma and psychosis, studied Open Dialogue in Finland and Peer-supported Open Dialogue in the UK in order to practice and teach as a team. In 2011, they joined with Robert Whitaker to found the Mad in America website

4 COMMENTS

LEAVE A REPLY